Scientists have taken skin cells from a woman suffering from type 1 diabetes, reprogrammed them into embryonic stem cells, and then converted those cells into insulin-producing cells in mice, according to a new study.

The announcement, which comes soon after another stem cell success involving therapeutic cloning, was published Monday in the journal Nature.

"This advance brings us a significant step closer to the development of cell replacement therapies," said senior study author Dieter Egli, a researcher at the New York Stem Cell Foundation.

Embryonic stem cells, or pluripotent cells, are cells that can reproduce endlessly and transform themselves into any type of human tissue. Researchers hope that the cells will one day be used to create transplant tissues that will not be rejected by the patient's body, because they carry their own DNA.

Egli and his colleagues used a cloning technique known as somatic cell nuclear transfer, or SCNT -- a process similar to the one used to clone "Dolly" the sheep in 1996.

The process involves removing the nucleus from a human egg cell, replacing it with the nucleus from a foreign "donor" cell, and then allowing the egg to divide and develop for a period of days. The developing embryo will contain a mass of pluripotent cells, which are removed and used to create a line of reproducing cells.

If the cloned embryo were implanted in the womb of a surrogate mother -- an act scientists consider unethical for a number of reasons -- it could possibly develop into a baby.

Up until now, the stem cell field has relied on a very different method of pluripotent cell production called induced pluripotency. The process is viewed as being much easier than SCNT, because it does not involve the controversial use of human egg cells, which are also difficult to obtain.

At a news conference, Egli told reporters that the SCNT process was becoming increasingly refined and should be viewed as a reliable source of pluripotent cells.

"For me this is the way to go," Egli said. "This is about reprogramming a patient's own cells, with their own genotype, with their own DNA that are immunologically matched to them and no one else, essentially. I think this is going to become a reality."

Read the original post:
Scientists report another embryonic cloning success

Comments are closed.